Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Guidant invests in lung device firm Spiration:

This article was originally published in Clinica

Executive Summary

Guidant has invested an undisclosed amount in equity in Spiration, a Redmond, Washington-based firm that develops and manufactures medical devices to treat lung diseases. Spiration is developing two products: a minimally invasive intra-bronchial valve to reduce lung volume in emphysema patients; and the VALR Surgical System, an alternative to surgical stapling and buttressing designed to minimise tissue trauma, air leaks and bleeding in lung surgery. Spiration raised $22m in its most recent financing round in June. Guidant's investment was made by the group's Compass medical technology venture capital unit.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts